AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
-2.38%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.22B
AUM Growth
+$65.4M
(+5.6%)
Cap. Flow
+$50.2M
Cap. Flow
% of AUM
4.1%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
93
New
22
Increased
25
Reduced
16
Closed
18
Top Buys
| 1 |
United Therapeutics
UTHR
|
$37.3M |
| 2 |
Avis
CAR
|
$32.1M |
| 3 |
Ralph Lauren
RL
|
$30M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$29.7M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$28.4M |
Top Sells
| 1 |
SGI
Somnigroup International Inc.
SGI
|
$40M |
| 2 |
United Parks & Resorts
PRKS
|
$34.4M |
| 3 |
CVS Health
CVS
|
$31.5M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$30.4M |
| 5 |
Incyte
INCY
|
$28.7M |
Sector Composition
| 1 | Healthcare | 50.4% |
| 2 | Consumer Discretionary | 26.38% |
| 3 | Consumer Staples | 10.32% |
| 4 | Industrials | 3.07% |
| 5 | Communication Services | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PetMed Express
PETS
$63M
| $17.6M | 1.05% |
+532,000
| New | +$17.6M |
|
27
Madrigal Pharmaceuticals
MDGL
$9.65B
| $17.1M | 1.03% |
+80,000
| New | +$17.1M |
|
|
CLLS
28
Cellectis
CLLS
$269M
| $16.9M | 1.02% |
+600,000
| New | +$16.9M |
|
29
Best Buy
BBY
$16.1B
| $15.9M | 0.95% |
200,000
+60,000
| +43% | +$4.76M |
|
|
GAP
30
The Gap, Inc.
GAP
$8.83B
| $15.1M | 0.91% |
524,000
-336,000
| -39% | -$9.69M |
|
31
Larimar Therapeutics
LRMR
$337M
| $13.6M | 0.82% |
97,000
-28,000
| -22% | -$3.93M |
|
|
SBBP
32
DELISTED
Strongbridge Biopharma plc.
SBBP
| $12.9M | 0.77% |
2,650,000
+492,000
| +23% | +$2.39M |
|
|
BLUE
33
DELISTED
bluebird bio
BLUE
| $12.8M | 0.77% |
6,794
-7,102
| -51% | -$13.4M |
|
|
ONCE
34
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $12.4M | 0.75% |
228,000
+78,000
| +52% | +$4.25M |
|
|
RDUS
35
DELISTED
Radius Health, Inc.
RDUS
| $11.7M | 0.7% |
+658,000
| New | +$11.7M |
|
|
PRTK
36
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $11.6M | 0.7% |
1,200,000
+68,000
| +6% | +$660K |
|
37
Alphatec Holdings
ATEC
$2.43B
| $11.1M | 0.67% |
3,300,414
+70,000
| +2% | +$236K |
|
38
Brinker International
EAT
$7.04B
| $9.35M | 0.56% |
+200,000
| New | +$9.35M |
|
|
BDSI
39
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $9.22M | 0.55% |
3,292,000
+3,171,111
| +2,623% | +$8.88M |
|
40
Floor & Decor
FND
$9.42B
| $9.05M | 0.54% |
+300,000
| New | +$9.05M |
|
41
Meta Platforms (Facebook)
META
$1.89T
| $8.22M | 0.49% |
50,000
+32,000
| +178% | +$5.26M |
|
42
lululemon athletica
LULU
$19.9B
| $8.13M | 0.49% |
+50,000
| New | +$8.13M |
|
|
43
CVS Health
CVS
$93.6B
| $7.87M | 0.47% |
100,000
-400,000
| -80% | -$31.5M |
|
44
Solid Biosciences
SLDB
$428M
| $7.74M | 0.46% |
10,933
-1,067
| -9% | -$755K |
|
|
TLRD
45
DELISTED
Tailored Brands, Inc.
TLRD
| $7.56M | 0.45% |
+300,000
| New | +$7.56M |
|
|
ACHN
46
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $7.36M | 0.44% |
2,000,000
-2,000,000
| -50% | -$7.36M |
|
|
ALIM
47
DELISTED
Alimera Sciences, Inc.
ALIM
| $6.8M | 0.41% |
462,400
| – | – |
|
48
Catalyst Pharmaceutical
CPRX
$2.48B
| $6.32M | 0.38% |
1,672,000
-28,000
| -2% | -$106K |
|
|
FRTX
49
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $5.97M | 0.36% |
13,843
| – | – |
|
|
NVLN
50
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $5.49M | 0.33% |
1,856,000
| – | – |
|